Evaluation of hepatocyte growth factor as a sensitive marker for early detection of acute renal allograft rejection

Transplantation

Volumn 83, Issue 8, 2007, Pages 1035-1040

  Mahmoud, Khaled ^a   Opelz, Gerhard ^a   Pelzl, Steffen ^a   Daniel, Volker ^a   Sommerer, Claudia ^a   Zeier, Martin ^a   Schmidt, Jan ^a   Schönemann, Constanze ^b   Schnülle, Peter ^c   Süsal, Caner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF MANNHEIM   (Germany)

Author keywords

Acute allograft rejection; Hepatocyte growth factor; Immune monitoring; Kidney transplantation

Indexed keywords

CD30 ANTIGEN; SCATTER FACTOR;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

ADULT; BIOLOGICAL MARKERS; BIOPSY; FEMALE; GRAFT REJECTION; HEALTH; HEPATOCYTE GROWTH FACTOR; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS;

EID: 34247471572     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000259653.41436.24     Document Type: Article

References (26)

1. Knight RJ, Burrows L, Bodian C. The influence of acute rejection on long-term renal allograft survival: a comparison of living and cadaveric donor transplantation. Transplantation 2001; 15: 69.
2. Gjertson DW. Center and other factor effects in recipients of living-donor kidney transplants. Clin Transpl 2001; 15: 209.
3. Moss A, Najarian JS, Sutherland DE, et al. 5,000 kidney transplants: a single-center experience. Clin Transpl 2000; 14: 159.
4. Opelz G. Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients. The Collaborative Transplant Study. Transplant Proc 1997; 29: 73.
5. Salgado O. Noninvasive acute rejection diagnosis in kidney transplantation. Transplant Proc 2002; 34: 2543.
6. Perella RR, Duerinckx AJ, Tessler FN, et al. Evaluation of renal transplant dysfunction by duplex Doppler sonography: a prospective study and review of the literature. Am J Kidney Dis 1990; 15: 544.
7. Al-Awwa IA, Hariharan S. Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis. Am J Kidney Dis 1998; 31(Suppl 1): S15.
8. Pascual M, Vallhonrat H, Cosimi AB, et al. The clinical usefulness of the renal allograft biopsy in the cyclosporine era: a prospective study. Transplantation 1999; 67: 737.
9. Wiecek A, Nowicki M, Kokot F, Ritz E. Acute failure of the transplanted kidney-pathophysiology, diagnosis and prevention. Ann Transplant 1996; 1: 5.
10. Curtis JJ, Julian BA, Sanders CE, et al. Dilemmas in renal transplantation: when the clinical course and histiological findings differ. Am J Kidney Dis 1996; 27: 435.
11. Rebhandl W, Felberbauer FX, Resch S, et al. Value of circulating immune parameters in renal transplantation. Transplant Proc 1997; 29: 1881.
12. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995; 129: 1177.
13. Weidner KM, Arakaki N, Hartmann G, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 1991; 88: 7001.
14. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure, rules in liver regeneration, and other biological functions. Crit Rev Oncog 1992; 3: 27.
15. Kawaida K, Matsumoto K, Shimizu H, Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 1994; 91: 4357.
16. Millar SB, Martin DR, Kissane J, Hammerman MR. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol 1994; 266: 134.
17. Yoshimura R, Watanabe Y, Kasai S, et al. Hepatocyte growth factor (HGF) as a rapid diagnostic marker and its potential in the prevention of acute renal rejection. Transpl Int 2002; 15: 156.
18. Takada S, Namiki M, Takahara S, et al. Serum HGF levels in acute renal rejection after living related renal transplantation. Transpl Int 1996; 9: 151.
19. Pelzl S, Opelz G, Daniel V, et al. Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection. Transplantation 2003; 15: 421.
20. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561.
21. Igawa T, Kanda S, Kanetake H, et al. Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochem Biophys Res Commun 1991; 31: 831.
22. Matsumoto K, Nakamura T. Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases. Kidney Int 2001; 59: 2023.
23. Rampino T, Libetta C, De Simone W, et al. Hemodialysis stimulates hepatocyte growth factor release. Kidney Int 1998; 53: 1382.
24. Sugimura K, Kim T, Goto T, et al. Serum hepatocyte growth factor levels in patients with chronic renal failure. Nephron 1995; 70: 324.
25. Huraib S, Goldberg H, Katz A, et al. Percutaneous needle biopsy of the transplanted kidney: technique and complications. Am J Kidney Dis 1989; 14: 13.
26. Beckingham IJ, Nicholson ML, Bell PR. Analysis of factors associated with complications following renal transplant needle core biopsy. Br J Urol 1994; 73: 13.